Tfc Financial Management Protagonist Therapeutics, Inc Transaction History
Tfc Financial Management
- $650 Million
- Q1 2025
A detailed history of Tfc Financial Management transactions in Protagonist Therapeutics, Inc stock. As of the latest transaction made, Tfc Financial Management holds 1 shares of PTGX stock, worth $44. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1Holding current value
$44% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding PTGX
# of Institutions
252Shares Held
58MCall Options Held
226KPut Options Held
218K-
Farallon Capital Management LLC San Francisco, CA5.93MShares$266 Million1.22% of portfolio
-
Black Rock Inc. New York, NY5.76MShares$258 Million0.0% of portfolio
-
Rtw Investments, LP New York, NY5.5MShares$247 Million3.46% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.22MShares$189 Million0.0% of portfolio
-
State Street Corp Boston, MA3.33MShares$149 Million0.01% of portfolio
About Protagonist Therapeutics, Inc
- Ticker PTGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,084,100
- Market Cap $2.2B
- Description
- Protagonist Therapeutics, Inc., a biopharmaceutical company, discovers and develops peptide-based therapeutic drugs to address hematology and blood disorders, and inflammatory and immunomodulatory diseases. It is developing rusfertide (PTG-300), an injectable hepcidin mimetic that is in Phase II clinical trials for the treatment of patients with...